Ocimum Labs was incorporated in July, 2018 in Hyderabad, India and launched its R&D operations with a state-of-the-art R&D facility setup in January,2019

We focus on core expertise of Process Research & Development capabilities in selecting the differentiated API portfolio that will serve the global pharmaceutical markets. Our purpose is to provide high quality, cost effective Key Starting materials, Intermediates and Active Pharmaceutical Ingredients (API’s) and to become the strategic partner to the pharmaceutical companies by providing timely and quality support as part of pharmaceutical supply chain.We offer a broad and integrated portfolio of products and services to the global pharmaceutical industry. To facilitate our goal, Ocimum Labs plans to setup the manufacturing facility with 230KL capacity at Atchutapuram SEZ, Visakhapatnam -India.


To be the most “VALUED” pharma company by offering “HIGH QUALITY” Intermediates and API manufacturing services


To emerge as “VALUED” and reliable partner by providing “HIGH QUALITY” products towards global pharma with “RESEARCH” driven manufacturing capabilities


Effectively leveraging R&D to commercial through constant cost improvement process, thus gaining the competitive advantage Volume based approach vide development to commercial